Chemoprevention of oral cancer: Green tea experience

Journal of Natural Science, Biology and Medicine

Volumn 5, Issue 1, 2014, Pages 3-7

  Ramshankar, Vijayalakshmi ^a   Krishnamurthy, Arvind ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Chemoprevention; epigallocatechin 3 gallate; green tea extract

Indexed keywords

EID: 84897638233     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.127272     Document Type: Article

References (45)

1. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues (retinoids). Fed Proc 1976;35:1332-8.
2. Rajamanickam S, Agarwal R. Natural products and colon cancer: Current status and future prospects. Drug Dev Res 2008;69:460-71.
3. Manson MM, Farmer PB, Gescher A, Steward WP. Innovative agents in cancer prevention. Recent Results Cancer Res 2005;166:257-75.
4. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 2005;24:450-3.
5. Graham HN. Green tea composition, consumption and polyphenol chemistry. Prev Med 1992;21:334-50.
6. Mukhtar H, Ahmad N. Tea polyphenols: Prevention of cancer and optimizing health. Am J Clin Nutr 2000;71 (6 Suppl):1698-702S.
7. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
8. Wu BT, Hung PF, Chen HC, Huang RN, Chang HH, Kao YH. The apoptotic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the Cdk2 pathway. J Agric Food Chem 2005;53:5695-701.
9. Imai K, Suga K, Nakachi K. Cancer preventive effects of drinking tea among a Japanese population. Prev Med 1997;26:769-75.
10. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997;387:561.
11. Liao S, Hiipakka RA. Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophy Res Commun 1995;214:833-8.
12. Suganuma M, Okabe S, Sueoka N, Sueoka E, Matsuyama S, Imai K, et al. Green tea and cancer chemoprevention. Mutat Res 1999;428:339-44.
13. Lin AM, Chyi BY, Wu LY, Hwang LS, Ho LT. The antioxidative property of green tea against iron-induced oxidative stress in rat brain. Chin J Physiol 1998;41:189-94.
14. Cao Y, Cao R, Bråkenhielm E. Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr Biochem 2002;13:380-90.
15. Sazuka M, Isenmura M, Isemura S. Interaction between the carboxyl-terminal heparin-binding domain of fibronectin and (-)-epigallocatechin gallate. Biosci Biotechnol Biochem 1998;62:1031-2.
16. Hayakawa S, Saeki K, Sazuka M, Suzuki Y, Shoji Y, Ohta T, et al. Apoptosis induction by epigallocatechin gallate involves binding to Fas. Biochem Biophys Res Commun 2001;285:1102-6.
17. Suzuki Y, Isemura M. Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Lett 2001;173:15-20.
18. Ermakova S, Chol BY, Chol HS. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem 2005;280:16882-90.
19. Shim JH, Choi HS, Pugliese A, Lee SY, Chae JI, Choi BY, et al. (-)-Epigallocatechin gallate regulates CD3-mediated T cell mediator signaling in leukemia through the inhibition of ZAP 70 kinase. J Biol Chem 2008;283:28370-9.
20. Li M, He Z, Ermakova S, Zheng D, Tang F, Cho YY, et al. Direct Inhibition of insulin like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev 2007;16:598-605.
21. Ermakova SP, Kang BS, Choi BY, Choi HS, Schuster TF, Ma WY, et al. Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose regulated protein 78. Cancer Res 2006;66:9260-9.
22. Hastak K, Agarwal MK, Mukhtar H, Agarwal ML. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J 2005;19:786-91.
23. Amin AR, Thakur VS, Paul RK, Feng GS, Qu CK, Mukhtar H, et al. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc Natl Acad Sci USA 2007;104:5419-24.
24. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-kappa B in epigallocatechin-3-gallate induced apoptosis of LNCaP cells. Oncogene 2003;22:4851-9.
25. Sartippour MR, Heber D, Ma J, Lu Q, Go VL, Nguyen M. Green tea and its catechins inhibit breast cancer xenografts. Nutr Cancer 2001;40:149-56.
26. Leong H, Mathur PS, Greene GL. Green tea catechins inhibits angiogenesis through suppression of STAT3 activation. Breast Cancer Res Treat 2009;117:505-15.
27. Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2002;2:350-9.
28. Yang GY, Liao J, Li C, Chung J, Yurkow EJ, Ho CT, et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H (2) O (2) production in transformed and non transformed human bronchial cell lines: Possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 21:2035-9.
29. Zhang XD, Zhao XY, Zhang M, Liang Y, Xu XH, D′Arcy C, et al. A case-control study on green tea consumption and risk of adult leukemia. Zhonguhua Liu Xing Bing Xue Za Zhi 2008;29:290-3.
30. Masuda M, Suzui M, Lim JT, Weinstein IB. Epigallocatechin-3-gallate inhibits activation of HER2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 2003;9:3486-91.
31. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3- gallate inhibits epidermal gowth factor receptor signaling pathway. Evidence of direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004;279:12755-62.
32. Syed DN, Afaq F, Kweon MH, Hadi N, Bhatia N, Spiegelman VS, et al. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 2007;26:673-82.
33. Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004;11:380-1.
34. Umeda D, Yano S, Yamada K, Tachibana H. Green tea polyphenol epigallocatechin-3-gallate signalling pathway through 67-kDa laminin receptor. J Biol Chem 2008;283:3050-8.
35. Hong WK, Endicott LM, Itri LM, Doos W, Batasakis JG, Bell R, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Eng J Med 1986;315:1501-5.
36. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, et al. Comparison of low-dose isotretoin with beta carotene to prevent oral carcinogenesis. N Eng J Med 1993;328:15-20.
37. Hong WK, Lippman LM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second and primary tumors with isotretinion in squamous-cell carcinoma of head and neck. N Eng J Med 1990;323:795-801.
38. Shin DM, Khuri FR, Murphy B, Garden AS, Clayman G, Francisco M, et al. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial. J Clin Oncol 2001;19:3010-7.
39. Pipadimitrakopoulou VA, Hong WK, Lee JS, Batsaki JG, Lippman SM. Low-dose isotretinion versus beta-carotene to prevent oral carcinogenesis: Long-term follow-up. J Natl Cancer Inst 1997;89:257-8.
40. Lippman SM, Spitz MR. Lung cancer chemoprevention: An integrated approach. J Clin Oncol 2001;19 (18 Suppl):74-82S.
41. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, et al. Randomised Phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and Stage II head and neck cancer patients. J Natl Cancer Inst 2006;98:441-50.
42. Li N, Han C, Chen J. Tea preparations protect against DMBA-induced oral carcinogenesis in hamsters. Nutr Cancer 1999;35:73-9.
43. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) 2009;2:931-41.
44. Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 1998;20:528-34.
45. Li N, Chen X, Han C, Chen J. Chemopreventive effect of tea and curcumin on DMBA-induced oral carcinogenesis in hamsters. Wei Sheng Yan Jiu 2002;31:354-7.